scholarly article | Q13442814 |
P356 | DOI | 10.1097/NEN.0000000000000081 |
P698 | PubMed publication ID | 24918640 |
P50 | author | Linda Chaabane | Q39188638 |
Caterina Bendotti | Q39188656 | ||
Nilo Riva | Q39188671 | ||
Angelo Quattrini | Q56451650 | ||
Teuta Domi | Q57005746 | ||
Giancarlo Comi | Q66759549 | ||
P2093 | author name string | Francesca Bianchi | |
Paola Podini | |||
Ubaldo Del Carro | |||
Federica Cerri | |||
Massimo Corbo | |||
Giorgia Dina | |||
Daniela Ungaro | |||
Marco Peviani | |||
Giorgia Spano | |||
P2860 | cites work | Progressive changes in microglia and macrophages in spinal cord and peripheral nerve in the transgenic rat model of amyotrophic lateral sclerosis | Q21245232 |
Role of axonal transport in neurodegenerative diseases | Q28284096 | ||
Deficits in axonal transport precede ALS symptoms in vivo | Q30497554 | ||
Inflammation in ALS and SMA: sorting out the good from the evil | Q33664711 | ||
Axonal mitochondrial clusters containing mutant SOD1 in transgenic models of ALS. | Q33742751 | ||
ALS-causing SOD1 mutants generate vascular changes prior to motor neuron degeneration | Q33954016 | ||
The epidemiology of motor neuron diseases: a review of recent studies | Q34417934 | ||
The brachial plexus branches to the pectoral muscles in adult rats: morphological aspects and morphometric normative data | Q34453882 | ||
Efficacy of minocycline in patients with amyotrophic lateral sclerosis: a phase III randomised trial. | Q34584573 | ||
Axon pathology in neurological disease: a neglected therapeutic target | Q34831556 | ||
Early changes of neuromuscular transmission in the SOD1(G93A) mice model of ALS start long before motor symptoms onset | Q34989403 | ||
Endogenous regulatory T lymphocytes ameliorate amyotrophic lateral sclerosis in mice and correlate with disease progression in patients with amyotrophic lateral sclerosis | Q34992177 | ||
The Role of immune and inflammatory mechanisms in ALS. | Q35238394 | ||
Detection of preclinical motor neurone loss in SOD1 mutation carriers using motor unit number estimation | Q35468233 | ||
Disruption of Mtmr2 produces CMT4B1-like neuropathy with myelin outfolding and impaired spermatogenesis | Q36322774 | ||
Axonal degeneration in motor neuron disease | Q36970066 | ||
Efficacy of thalidomide for the treatment of amyotrophic lateral sclerosis: a phase II open label clinical trial | Q37288200 | ||
Neuromuscular junction destruction during amyotrophic lateral sclerosis: insights from transgenic models | Q37455509 | ||
Activation of innate and humoral immunity in the peripheral nervous system of ALS transgenic mice | Q37469800 | ||
Chapter 6: Methods and protocols in peripheral nerve regeneration experimental research: part III-electrophysiological evaluation | Q37580159 | ||
Microglia in ALS: the good, the bad, and the resting | Q37592030 | ||
Review: neuromuscular synaptic vulnerability in motor neurone disease: amyotrophic lateral sclerosis and spinal muscular atrophy | Q37702459 | ||
The "dying-back" phenomenon of motor neurons in ALS. | Q37807909 | ||
Evidence-based drug treatment in amyotrophic lateral sclerosis and upcoming clinical trials | Q37823334 | ||
Amyotrophic lateral sclerosis: a neurovascular disease. | Q37883632 | ||
Inflammation and neurovascular changes in amyotrophic lateral sclerosis. | Q38056551 | ||
Concepts for regulation of axon integrity by enwrapping glia | Q38175969 | ||
The onset of amyotrophic lateral sclerosis | Q40089644 | ||
Sodium valproate exerts neuroprotective effects in vivo through CREB-binding protein-dependent mechanisms but does not improve survival in an amyotrophic lateral sclerosis mouse model | Q40128564 | ||
Disease progression of human SOD1 (G93A) transgenic ALS model rats | Q40366167 | ||
Familial amyotrophic lateral sclerosis with a mutation in exon 4 of the Cu/Zn superoxide dismutase gene: pathological and immunocytochemical changes | Q41187994 | ||
Impaired blood-brain and blood-spinal cord barriers in mutant SOD1-linked ALS rat. | Q42459722 | ||
Additive neuroprotective effects of creatine and cyclooxygenase 2 inhibitors in a transgenic mouse model of amyotrophic lateral sclerosis | Q44726519 | ||
Vasculitis-like neuropathy in amyotrophic lateral sclerosis unresponsive to treatment | Q44757477 | ||
Implications of ALS focality: rostral-caudal distribution of lower motor neuron loss postmortem | Q44929159 | ||
Thalidomide and lenalidomide extend survival in a transgenic mouse model of amyotrophic lateral sclerosis. | Q46970968 | ||
Degeneration of respiratory motor neurons in the SOD1 G93A transgenic rat model of ALS. | Q47751488 | ||
Relationship of microglial and astrocytic activation to disease onset and progression in a transgenic model of familial ALS. | Q47951637 | ||
Electrophysiological analysis of a murine model of motoneuron disease. | Q50544366 | ||
In vivo assessment of peripheral nerve regeneration by diffusion tensor imaging. | Q53270755 | ||
A central role for the ERK-signaling pathway in controlling Schwann cell plasticity and peripheral nerve regeneration in vivo. | Q54527244 | ||
Amyotrophic lateral sclerosis | Q55877676 | ||
Inhibition of p38 mitogen activated protein kinase activation and mutant SOD1G93A-induced motor neuron death | Q57244949 | ||
Mutant superoxide dismutase disrupts cytoplasmic dynein in motor neurons | Q57450096 | ||
Analysis of neuromuscular junctions and effects of anabolic steroid administration in the SOD1G93A mouse model of ALS | Q58852435 | ||
Chronic motor axonal neuropathy | Q58880724 | ||
Motor nerve biopsy: Clinical usefulness and histopathological criteria | Q58880727 | ||
P433 | issue | 7 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | amyotrophic lateral sclerosis | Q206901 |
P304 | page(s) | 658-670 | |
P577 | publication date | 2014-07-01 | |
P1433 | published in | Journal of Neuropathology & Experimental Neurology | Q15716771 |
P1476 | title | Defining peripheral nervous system dysfunction in the SOD-1G93A transgenic rat model of amyotrophic lateral sclerosis | |
P478 | volume | 73 |
Q41380885 | Neurodevelopmental Malformations of the Cerebellar Vermis in Genetically Engineered Rats |
Q48278519 | Peripheral nerve diffusion tensor imaging as a measure of disease progression in ALS. |
Q53185951 | Quantifying disease progression in amyotrophic lateral sclerosis using peripheral nerve sonography. |
Q98184087 | Retromer stabilization results in neuroprotection in a model of Amyotrophic Lateral Sclerosis |
Q91781195 | The Peripheral Nervous System in Amyotrophic Lateral Sclerosis: Opportunities for Translational Research |
Search more.